Driven by Extraordinary
Expertise and Commitment
Our team is made up of veteran drug hunters and developers with deep experience in identifying, developing and commercializing medicines across disease indications and modalities. Together, we are on a mission to transform the standard of care for patients suffering from autoimmune and inflammatory diseases.
Leadership
“This is a culture of ‘can do,’ a culture of respect and a culture of trying to make a difference. The problems we’re solving will extend and improve the lives of real people and real families around the world.”
Visionary Investors
Since our founding in 2021 by OrbiMed and SR One, Odyssey Therapeutics has attracted
more than $500 million in funding from a diverse investor syndicate with a mix of funds
and investment strategies.
+ other institutional investors
Join Our Odyssey
If you’re ready to be part of something extraordinary, explore our career opportunities or reach out to us.
